Ritalin contraindications and warnings

Contraindications

The following provides information on contraindications to the use of methylphenidate in general, pregnancy & amp; Breastfeeding and children. Please note that the contraindications may vary depending on the dosage form of a drug (eg tablet, syringe, ointment).

When should methylphenidate not be used?

Methylphenidate must not be used with

  • Hypersensitivity to the active substance or other alpha-sympathomimetics
  • past drug dependence or drug or alcohol abuse
  • Diseases with schizophrenic symptoms, psychosis, depression and anxiety disorders
  • medically diagnosed or diagnosed tics, Tourette’s syndrome or other nerve-related disorders of movement
  • Hyperthyroidism (hyperthyroidism)
  • Hypertension
  • Cardiac arrhythmia with accelerated heartbeat and severe calcification of the coronary arteries (angina pectoris)
  • “intermittent claudication” arterial occlusive disease
  • Anorexia
  • Condition after a stroke
  • Hormone-producing tumors of the adrenal medulla (pheochromocytoma)
  • increased intraocular pressure (narrow-angle glaucoma)
  • enlarged prostate gland with residual urine formation
  • a therapy with antidepressants from the group of MAO inhibitors. There must be an interval of at least 14 days between treatment with methylphenidate and MAO inhibitors.

Only after careful consideration of the benefit and risk by the physician and under his control may methylphenidate be used in

  • Children with congenital heart disease
  • Pre-existing cardiovascular diseases and disorders of the brain’s blood supply
  • aggressive behavior because of the danger of aggravation
  • suicidal tendency
  • Epilepsy.

What should you watch out for during pregnancy and lactation?

Methylphenidate should not be taken during pregnancy and breast-feeding. Women of childbearing potential must use a reliable contraceptive method during treatment.

What should be considered in children?

Methylphenidate is approved for children over the age of six years, when experienced paediatricians or pediatric neurologists have identified the need for the treatment.

The drug should only be given after careful medical benefit-risk assessment and as part of a treatment concept of pedagogical, educational and psychotherapeutic help.

Every twelve months should an outlet attempt (slow reduction of the drug dose) clarify whether the further gift is really still necessary.

Warnings and Precautions

  • Alcohol increases the side effects of the drug on the brain and mind, so alcohol should not be drunk during the treatment.
  • The drug should not simply be discontinued, but slowly “swapped out” after consultation with the doctor.
  • In children, length growth should be controlled, as long-term treatment with the drug can easily slow growth.
  • If the medication is not used properly, there is a strong threat of mental dependence.
  • The drug can increase the spasm readiness. Therefore, if epileptics suffer from the treatment of frequent seizures, therapy should be stopped.
  • The drug may be used against Attention Deficit Disorder only by a specialist in behavioral disorders in children and adults, who must also supervise aftercare.
  • For long-term therapy with the drug, the blood count, blood pressure and weight should be checked regularly.
  • The drug can only be prescribed by the doctor on a special anesthetic (BtM) prescription.
  • The drug can give a positive result in testing for drug use and doping controls in sports.
  • Reactivity may be impaired by the drug to the extent that driving and operating machines are dangerous.

Sometimes medications release allergic reactions.
If you notice any signs of allergic reaction, tell your doctor or pharmacist immediately.